A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping to Evaluate the Safety and Efficacy of ENTR-601-45

NCT07038824 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Duchenne Muscular Dystrophy (DMD)

Interventions

DRUG: ENTR-601-45
DRUG: ENTR-601-45 - matching placebo

Sponsor

Entrada Therapeutics, Inc.